Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C)
Clinical trial NCT06004388 · COMPLETED
Trial details
- NCT number
- NCT06004388
- Sponsor
- Click Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-21
- Primary completion
- 2024-05-21
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.